Chronic spontaneous urticaria following ChAdOx1-S COVID-19 vaccination [0.03%]
接种ChAdOx1-S型新冠病毒疫苗后发生的慢性自发性荨麻疹病例
Dan Suan,Adrian Y S Lee
Dan Suan
White paper on peanut allergy - part 1: Epidemiology, burden of disease, health economic aspects [0.03%]
花生过敏白皮书-第一部分：流行病学、疾病负担、健康经济学方面
Lars Lange,Ludger Klimek,Kirsten Beyer et al.
Lars Lange et al.
Peanuts are Leguminosae, commonly known as the legume or pea family, and peanut allergy is among the most common food allergies and the most common cause of fatal food reactions and anaphylaxis. The prevalence of peanut allergy increased 3....
Messages for patients and relatives from the 2021 update of the guideline on acute therapy and management of anaphylaxis [0.03%]
2021版关于过敏性休克急性治疗和管理指南更新中给患者及家属的信息
Johannes Ring,Kirsten Beyer,Tilo Biedermann et al.
Johannes Ring et al.
Face masks suitable for preventing COVID-19 and pollen allergy. A study in the exposure chamber [0.03%]
适用于预防新冠肺炎和花粉过敏的口罩。舱内研究
Karl-Christian Bergmann,Sebastian Kugler,Torsten Zuberbier et al.
Karl-Christian Bergmann et al.
Background: Since the outbreak of the coronavirus pandemic, the population in Germany has been asked to wear face masks in public areas. The masks are accepted by the public. People with a pollen allergy have an interest ...
Answers to burning questions for clinical allergologists related to the new COVID-19 vaccines [0.03%]
与新型COVID-19疫苗相关的临床过敏病专家问答
Sabine Altrichter,Stefan Wöhrl,Fritz Horak et al.
Sabine Altrichter et al.
Background: Along with the newly approved vaccines against coronavirus disease 2019 (COVID-19), first reports of allergic or intolerance reactions were published. Subsequently, questions arose whether these vaccines pose ...
Immunologically relevant aspects of the new COVID-19 vaccines-an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper [0.03%]
关于新的COVID-19疫苗的免疫学相关方面——ÖGAI（奥地利过敏和临床免疫学会）及AeDA（德国应用过敏学会）立场文件
Eva Untersmayr,Elisabeth Förster-Waldl,Michael Bonelli et al.
Eva Untersmayr et al.
Background: The vaccines against the coronavirus disease 2019 (COVID-19) approved in the European Union represent a decisive step in the fight against the pandemic. The application of these available vaccines to patients ...
Use of telemedicine by practising allergists before and during the SARS-CoV-2 pandemic: A survey among members of the Association of German Allergists (AeDA) [0.03%]
德国变态反应协会(AeDA)会员在SARS-CoV-2大流行之前和期间进行远程医疗的使用情况调查
Stephanie Dramburg,Paolo Maria Matricardi,Ingrid Casper et al.
Stephanie Dramburg et al.
Background: The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic presented unprecedented challenges to both inpatient and outpatient care. In order to maintain good care under necessary contact r...
Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI [0.03%]
德国和奥地利变态反应学会(AeDA，DGAKI，GPA和ÖGAI)关于处理COVID-19疫苗过敏的立场文件及实用建议
Ludger Klimek,Karl-Christian Bergmann,Randolf Brehler et al.
Ludger Klimek et al.
Background: For the preventive treatment of the 2019 coronavirus disease (COVID-19) an unprecedented global research effort studied the safety and efficacy of new vaccine platforms that have not been previously used in hu...
Stefanie Gilles,Athanasios Damialis,Claudia Traidl-Hoffmann
Stefanie Gilles
Telemedicine in allergology: practical aspects: A position paper of the Association of German Allergists (AeDA) [0.03%]
过敏学远程医疗：实际操作问题：德国过敏学家协会(AeDA)立场文件
Stephanie Dramburg,Uso Walter,Sven Becker et al.
Stephanie Dramburg et al.
Since spring 2020, the wide-ranging contact restriction measures in the context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic have also led to a reduction in physician-patient contacts in the ambulatory care s...